
VERZENIO's Market Potential Soars as Demand for CDK4/6 Inhibitors Grows | DelveInsight
As VERZENIO gains traction in early-stage treatments and broadens its approved uses, its revenue is expected to keep growing. While the global CDK4/6 inhibitor market remains highly competitive, VERZENIO's distinct clinical advantages and ongoing …